Retinalamin schedules and visual-field testing in advanced glaucoma
Comparison in people · 2022
- What was studied
- 17 adults with advanced primary open-angle glaucoma, 34 eyes. Nine received courses every three months and eight every six months.
- Main finding
- Retinal photosensitivity did not change significantly in this 17-patient schedule comparison. Both groups received Retinalamin.
Reported findings and study design
Two active schedules compared with automated visual-field testing on different devices and programs.
Population or model 17 adults with advanced primary open-angle glaucoma, 34 eyes. Nine received courses every three months and eight every six months.
Dose, route and schedule
Repeat courses every three or six months. The paper describes intramuscular delivery. The administered mass was not verified from this report.
Protocol source ↗ · Original journal full text, methods and Tables 1–3.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Retinal photosensitivity | No statistically significant change | |
| Mean deviation across testing programs | −0.36 dB | 95% CI −4.27 to 3.54 |
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- No untreated arm. The 2024 OCT report has the same center, group sizes and schedules. It likely describes the same subgroup.
Related publications may describe some of the same participants or experiments.
Source details
Original journal full text, methods and Tables 1–3.
Sources checked
Citation
D. A. Dorofeev and colleagues. Retinalamin schedules and visual-field testing in advanced glaucoma Russian Open Medical Journal. 2022;11:e0109.
Study source ↗ · DOI 10.15275/rusomj.2022.0109 · Bibliography entry · Link to this summary